Jessica A Pollard (Jessica Pollard)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Palliative Care

Acute Myeloid Leukemia

Tyrosine Kinase

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Erica Brivio, Edoardo Pennesi, Marieke E Willemse, Alwin D R Huitema, Yilin Jiang, Harm D R van Tinteren, Vincent H J van der Velden, H Berna Beverloo, Monique L Den Boer, Lukas A J Rammeloo, Chad Hudson, Nyla Heerema, Karey Kowalski, Huadong Zhao, Luke Kuttschreuter, Francisco J Bautista Sirvent, Andrew Bukowinski, Carmelo Rizzari, Jessica A Pollard, Laura Murillo, Matthew Kutny, Sara Zarnegar, Michele S Redell, Stacy Cooper, Yves Bertrand, Arnaud Petit, Julie I Krystal, Markus Metzler, Donna Lancaster, Jean-Pierre Bourquin, Jayashree Motwani, Inge M Van der Sluis, Franco Locatelli, Michael E Roth, Nobuko Hijiya, Christian Michel Zwaan
Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Jessica A Pollard, Todd A Alonzo, Robert Gerbing, Patrick A Brown, Elizabeth Fox, John Kim Choi, Brian T Fisher, Betsy Hirsch, Samir B Kahwash, Kelly D Getz, John E Levine, Lisa Eidenschink Brodersen, Michael R Loken, Susana Raimondi, Katherine Tarlock, Andrew C Wood, Lillian Sung, Edward Anders Kolb, Alan S Gamis, Soheil Meshinchi, Richard Aplenc
Sorafenib in Combination With Standard Chemotherapy for Children With High Allelic Ratio FLT3 /ITD+ Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML1031. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (18) (2022)
Jessica A Pollard, Erin M Guest, Todd A Alonzo, Robert B Gerbing, Michael R Loken, Lisa Eidenschink Brodersen, E Anders Kolb, Richard Aplenc, Soheil Meshinchi, Susana C Raimondi, Betsy Hirsch, Alan S Gamis
Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric KMT2A-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (28) (2021)